Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
This helps control your appetite and prevent overeating
An excellent experience The order process was super easy with very little wait time for doctor approval
Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
This combination immediately raised red flags for medical professionals and informed individuals alike
Our data suggest that mesh vibrating nebulization is of interest for patients requiring immediate strong antiviral effect in the lung
Most patients begin experiencing changes within 812 weeks , with continued success as they progress with our guidance
US$ 29.18
US$ 23.54
US$ 28.48
US$ 28.75
US$ 24.83
US$ 28.18
US$ 20.91
US$ 21.01
US$ 25.86
US$ 21.11
